OptimiZation Of Lipid Lowering Therapies Using a Decision Support System In Patients With Acute Coronary Syndrome.

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1139 participants.

Also called NCT05844566

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose other
Phase
Not applicable
Enrolled
  • 1,139 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05844566
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Italy, Spain, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05844566. Randomized; single masking; primary purpose other. Start 2023-04-03 (actual); primary completion 2024-12-12 (actual). Results posted on 2026-02-19.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
OptimiZation Of Lipid Lowering Therapies Using a Decision Support System In Patients With Acute Coronary Syndrome.
Acronym
ZODIAC
Condition
Acute Coronary Syndrome
Intervention (Device)
Decision Support System (DSS)
Lead sponsor
Imperial College London (class: other)
Collaborator
Sanofi (class: industry)
Collaborator
Axtria, Inc. (class: not stated)
Collaborator
Hospital Universitario La Paz (class: other)
Collaborator
Hippocrates Research (class: other)

Record details

Record id
cardio:ct-nct05844566
Content hash
bf8491c9f2bce6622ef37e86ea128ee310405a4adcf114a8b50884f80efd4506